Our Competencies

When Symbiotix was founded in October 1998, we made a strategic decision that fundamentally shaped our business model and continues to guide us today. We elected to center our programming on science and to build our marketing around that element. Our belief is that no clinician changes his or her practice without logical and sound clinical rationale.

Furthermore, we opted to focus on and build specific competencies. Consequently, Symbiotix has established itself as a leader in several specific fields of medicine.

Strengthened by this approach, Symbiotix has formed relationships with the thought leaders within its competencies and achieves an in-depth understanding of their marketplace dynamics.

Symbiotix is a recognized leader in several
disease states and therapeutic areas

Our Competencies:

• Cardiology / hypertension
  
• Cystic Fibrosis
• Gastroenterology / Chronic Liver Disease
  
  • Hepatitis C (HCV)
  • Hepatitis B (HBV)
  • HIV/HCV Coinfection
  • HIV/HBV Coinfection
• HIV / AIDS
  
• Oncology
• Antitumor
• Supportive Care
• Immunomodulation
• Solid Organ Transplantation
• Hematology
• Anemia
• Hematologic Malignancies
• Pulmonary Arterial Hypertension
• Radiology / Diagnostic Imaging
• Respiratory Medicine